GenePharm's platform is a high throughput technology that combines state of art molecular biology and bioinformatics. The company has discovered a suite of proteins with new functions and therapeutic implications. These proteins are either secreted or membrane associated with potential as drugable proteins or drug target. We are also leveraging our technology to look for therapeutic proteins directly for specific diseases. Our ligand discovery technology is a powerful high throughput assay that can identify specific ligand for any given cell surface proteins.
